Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Hodgkin's LymphomaHodgkin???s Lymphoma

Project: Research project

Project Details

Description

Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Hodgkin's Lymphoma Hodgkin???s Lymphoma
StatusActive
Effective start/end date8/16/188/15/28

Funding

  • BRISTOL-MYERS SQUIBB COMPANY